Optaflexx™and Monovet® and Tylan™
Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States
-
Animal drug application
200646 -
Animal drug product ID
8716
What the source publishes
- Holder
- Huvepharma EOOD
- Active ingredients
- Monensin Ractopamine Hydrochloride Tylosin Phosphate
- Form
- Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds
- Routes
- Oral
- Supply regime
- VFD
Names this record is found by
Complete source data
{
"form": "Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds",
"name": "Optaflexx™and Monovet® and Tylan™",
"holder": "Huvepharma EOOD",
"routes": [
"Oral"
],
"smpcUrl": null,
"marketed": null,
"useDomain": "veterinary",
"leafletUrl": null,
"supplyRegime": "VFD",
"nativeProduct": {
"routes": [
"Oral"
],
"species": {
"Cattle:408": "Fed in confinement for slaughter"
},
"sortOrder": 1,
"withdrawals": [
"<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.</p><p></p>"
],
"doseFormName": "Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds",
"applicationId": null,
"specifications": "Optaflexx™: 45.4 g/lb (100 g/kg) of ractopamine hydrochloride, Monovet®: 90.7 g/lb of monensin, and Tylan™: 40 g/lb and 100g/lb of tylosin",
"proprietaryName": "Optaflexx™and Monovet® and Tylan™",
"proprietaryNameId": 8716,
"statusDescription": "VFD"
},
"nativeSummary": {
"noohDate": null,
"publishDate": "2020-02-21",
"sponsorName": "Huvepharma EOOD",
"applicationId": 6483,
"applicationType": "A",
"proprietaryName": "Optaflexx™and Monovet® and Tylan™\n",
"applicationNumber": 200646,
"activeIngredientName": "Monensin\nRactopamine Hydrochloride\nTylosin Phosphate\n",
"applicationStatusCode": "A",
"applicationStatusValue": null,
"voluntaryWithdrawalDate": null
},
"targetSpecies": [
{
"code": "408",
"label": "Cattle",
"native": {
"key": "Cattle:408",
"population": "Fed in confinement for slaughter"
},
"sourceId": "us.fda.animal-drugs",
"population": "Fed in confinement for slaughter",
"canonicalId": "cattle",
"mappingStatus": "mapped",
"mappingVersion": 1
}
],
"informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
"ingredientScope": "application-level; no product-specific composition inferred",
"nativePublishDate": "2020-02-21",
"sourceDisposition": "reviewed-veterinary-application-product",
"useDomainEvidence": {
"basis": "publisher-dataset-scope",
"field": "sourceId",
"value": "us.fda.animal-drugs",
"version": 1,
"sourceId": "us.fda.animal-drugs"
},
"withdrawalPeriods": [
{
"native": "<p>A withdrawal time has not been established for pre-ruminating calves. Do not use in calves to be processed for veal.</p><p></p>",
"status": "unparsed"
}
],
"patientEligibility": "not-assessed",
"nativeApplicationId": 6483,
"targetSpeciesStatus": "reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"activeIngredientsText": "Monensin\nRactopamine Hydrochloride\nTylosin Phosphate\n",
"nativeApplicationType": "A",
"applicationIngredients": [
{
"activeIngredientName": "Ractopamine Hydrochloride",
"activeIngredientTolerance": "The tolerance for ractopamine hydrochloride (the marker residue) in swine is 0.15 part per million) in liver (target tissue).<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in cattle is 0.03 part per million in muscle and 0.09 part per million in liver.<P>\r\n\r\nThe tolerance for ractopamine hydrochloride (the marker residue) in turkeys is 0.45 ppm in liver(target tissue) and 0.1 ppm in muscle.<P>\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t"
},
{
"activeIngredientName": "Monensin",
"activeIngredientTolerance": "<p>A tolerance of 0.05 part per million is established for negligible residues of monensin in the edible tissues of cattle and goats. A tolerance for residues of monensin in chickens, turkeys and quail is not needed.</p>"
},
{
"activeIngredientName": "Tylosin Phosphate",
"activeIngredientTolerance": "<p>Tolerances are established for residues of tylosin in edible products of animals as follows: a. Chickens and turkeys: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. b. Cattle: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. c. Swine: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. d. Milk: 0.05 part per million (negligible residue). e. Eggs: 0.2 part per million (negligible residue).</p>"
}
],
"nativeApplicationNumber": 200646,
"nativeProprietaryNameId": 8716,
"restrictionObservations": [
{
"indicationText": "<p><font size=\"2\"></font></p><p>For increased rate of weight gain and improved feed efficiency in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. </p>",
"limitationText": null,
"populationText": "Cattle fed in confinement for slaughter"
},
{
"indicationText": "<p>For increased rate of weight gain, improved feed efficiency, prevention and control of coccidiosis due to <em>Eimeria bovis </em>and <em>E. zuernii </em>and reduction of<br/>incidence of liver abscesses caused by <em>Fusobacterium necrophorum</em> and <em>Arcanobacterium</em> (<em>Actinomyces</em>) <em>pyogenes</em> in cattle fed in confinement for<br/>slaughter for the last 28 to 42 days on feed.<br/></p>",
"limitationText": null,
"populationText": "Cattle fed in confinement for slaughter"
},
{
"indicationText": "<p>For increased rate of weight gain, improved feed efficiency, increased carcass leanness, prevention and control of coccidiosis due to <em>Eimeria bovis </em>and <em>E.<br/>zuernii </em>and reduction of incidence of liver abscesses caused by <em>Fusobacterium necrophorum and Arcanobacterium </em>(<em>Actinomyces</em>) <em>pyogenes</em> in cattle fed in<br/>confinement for slaughter for the last 28 to 42 days on feed.<br/></p>",
"limitationText": null,
"populationText": "Cattle fed in confinement for slaughter"
}
],
"withdrawalPeriodsStatus": "reported-unparsed",
"publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
"nativeNoticeOfHearingDate": null,
"nativeApplicationStatusCode": "A",
"nativeVoluntaryWithdrawalDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.animal-drugs" \
--data-urlencode "id=us:fda:animaldrugs:6483:8716"